Cariprazine Completed Phase 2 Trials for Major Depressive Disorder (MDD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00854100Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
NCT01469377Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder